HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Cezmi Akdis Selected Research
Cezmi Akdis Research Topics
Disease
10
Asthma (Bronchial Asthma)
02/2024 - 06/2007
10
Hypersensitivity (Allergy)
01/2023 - 05/2007
7
Food Hypersensitivity (Food Allergy)
12/2021 - 01/2016
4
Anaphylaxis (Anaphylactic Shock)
01/2022 - 05/2007
3
Allergic Rhinitis
01/2023 - 06/2007
3
Inflammation (Inflammations)
01/2019 - 11/2014
2
Atopic Dermatitis (Atopic Eczema)
11/2020 - 11/2013
1
Coinfection
11/2023
1
Respiratory Sounds (Crackle)
11/2023
1
Convalescence
11/2023
1
Sepsis (Septicemia)
01/2022
1
Chronic Disease (Chronic Diseases)
01/2020
1
COVID-19
01/2020
1
Drug Hypersensitivity (Drug Allergy)
12/2019
1
Immediate Hypersensitivity
11/2018
1
Rhinitis
01/2017
1
Eczema
01/2017
1
Infections
04/2015
1
Communicable Diseases (Infectious Diseases)
04/2015
1
Lymphoma (Lymphomas)
11/2013
1
Neoplasms (Cancer)
11/2013
1
Angioedema
04/2012
1
Rhinosinusitis
06/2008
Drug/Important Bio-Agent (IBA)
10
Immunoglobulin E (IgE)
IBA
12/2021 - 05/2007
8
Allergens
IBA
01/2022 - 05/2007
3
Cytokines
IBA
11/2023 - 06/2008
3
dupilumab
IBA
01/2020 - 01/2020
2
COVID-19 Vaccines
IBA
12/2021 - 01/2021
2
Immunoglobulin G (IgG)
IBA
01/2021 - 06/2007
2
benralizumab
IBA
01/2020 - 01/2020
2
Butyrates (Butyrate)
IBA
01/2020 - 01/2019
2
Monoclonal Antibodies
IBA
01/2020 - 01/2020
2
Omalizumab (Xolair)
FDA Link
01/2020 - 01/2020
1
1,3-dichloro-1-propene (1,3-dichloropropene)
IBA
02/2024
1
Air Pollutants (Pollutants, Air)
IBA
02/2024
1
Environmental Pollutants (Pollutants, Environmental)
IBA
02/2024
1
Chemokine CX3CL1
IBA
11/2023
1
Interleukin-8 (Interleukin 8)
IBA
11/2023
1
Epidermal Growth Factor (EGF)
IBA
11/2023
1
Iron-Dextran Complex (InFed)
FDA Link
01/2023
1
Cannabinoids
IBA
01/2022
1
Excipients (Suspending Agents)
IBA
12/2021
1
Polyethylene Glycols (Polyethylene Glycol)
FDA Link
Generic
12/2021
1
Interleukin-13
IBA
01/2021
1
mRNA Vaccines
IBA
01/2021
1
Messenger RNA (mRNA)
IBA
01/2021
1
Vaccines
IBA
01/2021
1
Interleukin-4 (Interleukin 4)
IBA
01/2021
1
Interleukin-5 (Interleukin 5)
IBA
01/2021
1
reslizumab
IBA
01/2020
1
Interleukin-4 Receptors (Interleukin 4 Receptor)
IBA
01/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020
1
Volatile Fatty Acids
IBA
01/2020
1
mepolizumab
IBA
01/2020
1
insulin receptor-related receptor (IRR)
IBA
01/2020
1
Propionates
IBA
01/2019
1
Antigens
IBA
11/2018
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
04/2015
1
Autoantibodies
IBA
04/2015
1
Volatile Organic Compounds
IBA
11/2014
1
pimecrolimus (Elidel)
FDA Link
11/2013
1
Calcineurin Inhibitors
IBA
11/2013
1
Immunoglobulin A (IgA)
IBA
06/2007
1
Phospholipases A2 (Phospholipase A2)
IBA
05/2007
1
Hyaluronoglucosaminidase (Hyaluronidase)
FDA Link
05/2007
1
Bee Venoms (Bee Venom)
IBA
05/2007
Therapy/Procedure
5
Therapeutics
01/2022 - 04/2012
4
Immunotherapy
12/2019 - 05/2007
2
Precision Medicine
11/2020 - 01/2017
1
Oral Administration
01/2019